Jeong, Y., Tantry, U. S., Park, Y., Kwon, T. J., Park, J. R., Hwang, S., . . . Gurbel, P. A. (2012). Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention. American Diabetes Association.
Chicago Style CitationJeong, Young-Hoon, et al. Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention. American Diabetes Association, 2012.
Cita MLAJeong, Young-Hoon, et al. Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention. American Diabetes Association, 2012.